Cancer trial aims to cut side effects

A GROUNDBREAKING trial for a prostate cancer treatment with fewer side effects has launched in the UK, researchers have said.

- 

Backed by the UK Government-funded National Institute for Health and Care Research (NIHR), the trial will examine whether Aquablation - a therapy using robotics, AI and real-time imaging - works as well or better than traditional surgery, known as radical prostatectomy.

With radical prostatectomy, the entire prostate gland is removed in a bid to cure men of prostate cancer.

However, the operation carries a risk of serious side effects, such as infection, erectile dysfunction and urinary problems.